520 related articles for article (PubMed ID: 9072543)
1. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
Thamilselvan S; Hackett RL; Khan SR
J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
[TBL] [Abstract][Full Text] [Related]
2. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
Thamilselvan S; Menon M
BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
[TBL] [Abstract][Full Text] [Related]
3. Oxalate and calcium oxalate crystals are injurious to renal epithelial cells: results of in vivo and in vitro studies.
Thamilselvan S; Khan SR
J Nephrol; 1998; 11 Suppl 1():66-9. PubMed ID: 9604816
[TBL] [Abstract][Full Text] [Related]
4. Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis.
Gambaro G; Valente ML; Zanetti E; Della Barbera M; Del Prete D; D'Angelo A; Trevisan A
J Am Soc Nephrol; 2006 Aug; 17(8):2213-9. PubMed ID: 16790510
[TBL] [Abstract][Full Text] [Related]
5. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
Khan SR; Thamilselvan S
Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
[TBL] [Abstract][Full Text] [Related]
6. Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals.
Huang HS; Ma MC; Chen J; Chen CF
Neurourol Urodyn; 2003; 22(2):176-82. PubMed ID: 12579636
[TBL] [Abstract][Full Text] [Related]
7. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
[TBL] [Abstract][Full Text] [Related]
8. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
[TBL] [Abstract][Full Text] [Related]
9. Experimental calcium oxalate nephrolithiasis and the formation of human urinary stones.
Khan SR
Scanning Microsc; 1995 Mar; 9(1):89-100; discussion 100-1. PubMed ID: 8553028
[TBL] [Abstract][Full Text] [Related]
10. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
[TBL] [Abstract][Full Text] [Related]
11. Etiology of experimental calcium oxalate monohydrate nephrolithiasis in rats.
de Bruijn WC; Boevé ER; van Run PR; van Miert PP; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
Scanning Microsc; 1994; 8(3):541-9; discussion 549-50. PubMed ID: 7747156
[TBL] [Abstract][Full Text] [Related]
12. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
[TBL] [Abstract][Full Text] [Related]
13. Dietary oxalate and calcium oxalate nephrolithiasis.
Khan SR; Glenton PA; Byer KJ
J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
[TBL] [Abstract][Full Text] [Related]
14. Renal peroxidative changes mediated by oxalate: the protective role of fucoidan.
Veena CK; Josephine A; Preetha SP; Varalakshmi P; Sundarapandiyan R
Life Sci; 2006 Oct; 79(19):1789-95. PubMed ID: 16820173
[TBL] [Abstract][Full Text] [Related]
15. Antiurolithic effect of lupeol and lupeol linoleate in experimental hyperoxaluria.
Sudhahar V; Veena CK; Varalakshmi P
J Nat Prod; 2008 Sep; 71(9):1509-12. PubMed ID: 18717586
[TBL] [Abstract][Full Text] [Related]
16. [Urinary calcium oxalate supersaturation beyond nephrolithiasis. Relationship with tubulointerstitial damage].
Toblli JE; Angerosa M; Stella I; Ferder L; Inserra F
Medicina (B Aires); 2003; 63(2):97-104. PubMed ID: 12793076
[TBL] [Abstract][Full Text] [Related]
17. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
[TBL] [Abstract][Full Text] [Related]
18. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
Khan SR; Glenton PA; Byer KJ
Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
[TBL] [Abstract][Full Text] [Related]
19. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats.
Green ML; Freel RW; Hatch M
Kidney Int; 2005 Dec; 68(6):2629-38. PubMed ID: 16316339
[TBL] [Abstract][Full Text] [Related]
20. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
Moriyama MT; Glenton PA; Khan SR
J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
